Cart
sales@molnova.com
Home - Products - Others - Other Targets - Concizumab

Concizumab

CAS No. 1312299-39-0

Concizumab( —— )

Catalog No. M36873 CAS No. 1312299-39-0

Concizumab is an anti-TFPI monoclonal antibody (IgG4 type) that selectively binds to the Kunitz protease inhibitor (KPI) 2 domain of TFPI, blocking its interaction with the FXa active site.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 560 In Stock
10MG 919 In Stock
25MG 1359 In Stock
50MG 1795 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock
Get Quotation Bulk Inquiry Add to Cart

Biological Information

  • Product Name
    Concizumab
  • Note
    Research use only, not for human use.
  • Brief Description
    Concizumab is an anti-TFPI monoclonal antibody (IgG4 type) that selectively binds to the Kunitz protease inhibitor (KPI) 2 domain of TFPI, blocking its interaction with the FXa active site.
  • Description
    Concizumab is an anti-TFPI monoclonal antibody (IgG4 type) that binds to the Kunitz-type protease inhibitor (KPI) 2 structural domain of TFPI, thereby blocking the interaction of this structural domain with the FXa active site. Concizumab can be used in the study of haemophilia.
  • In Vitro
    ——
  • In Vivo
    Animal Model:Cynomolgus monkeys (target mediated drug disposition (TMDD) model).Dosage:20mg/kg or 200 mg/kg Administration:Intravenous injection/subcutaneous injection Result:Showed a high bioavailability (93%) and the absorption half-life is estimated to be 72 h.
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1312299-39-0
  • Formula Weight
  • Molecular Formula
    ——
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    ——
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Kjalke M, et al. Thrombin generation potential in the presence of concizumab and rFVIIa, APCC, rFVIII, or rFIX: In vitro and ex vivo analyses. J Thromb Haemost. 2021 Jul;19(7):1687-1696. ?
Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog
related products

  • Naringenin (b)

    Naringenin is a flavanone that is considered to have a bioactive effect on human health as antioxidant, free radical scavenger, antiinflammatory, carbohydrate metabolism promoter, immunity system modulater.

  • Hydrazinium hydroxid...

    Hydrazinium hydroxide is a bioactive compound.

  • (4R,4aS,5R)-2,3,4a,5...

    (4R,4aS,5R)-2,3,4a,5,6,7-Hexahydro-4-hydroxy-4a,5-dimethyl-1(4H)-naphthalenone

Sign In Join Free